vs
InterDigital, Inc.（IDCC）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是InterDigital, Inc.的1.0倍（$207.3M vs $205.4M），InterDigital, Inc.净利率更高（36.7% vs -62.0%，领先98.7%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -2.4%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -4.1%）
InterDigital, Inc.是一家美国科技研发企业，成立于1972年，于纳斯达克挂牌上市，为标普600指数成分股，面向全球市场为移动设备、通信网络及相关服务领域提供无线与视频技术解决方案，在相关技术研发领域拥有深厚积累。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
IDCC vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $205.4M | $207.3M |
| 净利润 | $75.3M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 40.0% | -54.7% |
| 净利率 | 36.7% | -62.0% |
| 营收同比 | -2.4% | 25.9% |
| 净利润同比 | -34.8% | 3.5% |
| 每股收益（稀释后） | $2.14 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $205.4M | — | ||
| Q4 25 | $158.2M | $207.3M | ||
| Q3 25 | $164.7M | $159.9M | ||
| Q2 25 | $300.6M | $166.5M | ||
| Q1 25 | $210.5M | $139.3M | ||
| Q4 24 | $252.8M | $164.6M | ||
| Q3 24 | $128.7M | $139.5M | ||
| Q2 24 | $223.5M | $147.0M |
| Q1 26 | $75.3M | — | ||
| Q4 25 | $43.0M | $-128.6M | ||
| Q3 25 | $67.5M | $-180.4M | ||
| Q2 25 | $180.6M | $-115.0M | ||
| Q1 25 | $115.6M | $-151.1M | ||
| Q4 24 | $133.1M | $-133.2M | ||
| Q3 24 | $34.2M | $-133.5M | ||
| Q2 24 | $109.7M | $-131.6M |
| Q1 26 | 40.0% | — | ||
| Q4 25 | 30.2% | -54.7% | ||
| Q3 25 | 46.0% | -106.9% | ||
| Q2 25 | 68.3% | -64.8% | ||
| Q1 25 | 62.6% | -102.6% | ||
| Q4 24 | 64.3% | -74.3% | ||
| Q3 24 | 30.6% | -94.6% | ||
| Q2 24 | 59.9% | -79.1% |
| Q1 26 | 36.7% | — | ||
| Q4 25 | 27.2% | -62.0% | ||
| Q3 25 | 41.0% | -112.8% | ||
| Q2 25 | 60.1% | -69.0% | ||
| Q1 25 | 54.9% | -108.5% | ||
| Q4 24 | 52.7% | -80.9% | ||
| Q3 24 | 26.6% | -95.7% | ||
| Q2 24 | 49.1% | -89.5% |
| Q1 26 | $2.14 | — | ||
| Q4 25 | $1.07 | $-1.28 | ||
| Q3 25 | $1.93 | $-1.81 | ||
| Q2 25 | $5.35 | $-1.17 | ||
| Q1 25 | $3.45 | $-1.57 | ||
| Q4 24 | $4.12 | $-1.34 | ||
| Q3 24 | $1.14 | $-1.40 | ||
| Q2 24 | $3.93 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $421.0M |
| 总债务越低越好 | $377.8M | — |
| 股东权益账面价值 | $1.1B | $-80.0M |
| 总资产 | $2.1B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $421.0M | ||
| Q3 25 | $1.3B | $202.5M | ||
| Q2 25 | $937.0M | $176.3M | ||
| Q1 25 | $883.3M | $127.1M | ||
| Q4 24 | $958.2M | $174.0M | ||
| Q3 24 | $813.2M | $150.6M | ||
| Q2 24 | $760.3M | $480.7M |
| Q1 26 | $377.8M | — | ||
| Q4 25 | $16.3M | — | ||
| Q3 25 | $17.1M | — | ||
| Q2 25 | $16.6M | — | ||
| Q1 25 | $16.0M | — | ||
| Q4 24 | $15.4M | — | ||
| Q3 24 | $18.3M | — | ||
| Q2 24 | $17.7M | — |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $-80.0M | ||
| Q3 25 | $1.1B | $9.2M | ||
| Q2 25 | $1.1B | $151.3M | ||
| Q1 25 | $936.9M | $144.2M | ||
| Q4 24 | $857.2M | $255.0M | ||
| Q3 24 | $722.5M | $346.8M | ||
| Q2 24 | $696.8M | $432.4M |
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $1.5B | ||
| Q3 25 | $2.1B | $1.2B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $1.9B | $1.3B | ||
| Q4 24 | $1.8B | $1.5B | ||
| Q3 24 | $1.7B | $1.5B | ||
| Q2 24 | $1.6B | $1.6B |
| Q1 26 | 0.34× | — | ||
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.02× | — | ||
| Q2 25 | 0.02× | — | ||
| Q1 25 | 0.02× | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | 0.03× | — | ||
| Q2 24 | 0.03× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $544.5M | $-99.8M | ||
| Q3 25 | $395.9M | $-91.4M | ||
| Q2 25 | $105.1M | $-108.3M | ||
| Q1 25 | $-20.0M | $-166.5M | ||
| Q4 24 | $271.5M | $-79.3M | ||
| Q3 24 | $77.6M | $-67.0M | ||
| Q2 24 | $-48.9M | $-77.0M |
| Q1 26 | — | — | ||
| Q4 25 | $528.6M | $-100.8M | ||
| Q3 25 | $395.3M | $-92.7M | ||
| Q2 25 | $104.5M | $-110.7M | ||
| Q1 25 | $-34.5M | $-167.8M | ||
| Q4 24 | $265.7M | $-79.5M | ||
| Q3 24 | $76.7M | $-68.6M | ||
| Q2 24 | $-49.5M | $-79.0M |
| Q1 26 | — | — | ||
| Q4 25 | 334.0% | -48.6% | ||
| Q3 25 | 240.1% | -58.0% | ||
| Q2 25 | 34.8% | -66.5% | ||
| Q1 25 | -16.4% | -120.5% | ||
| Q4 24 | 105.1% | -48.3% | ||
| Q3 24 | 59.6% | -49.2% | ||
| Q2 24 | -22.1% | -53.7% |
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | 0.5% | ||
| Q3 25 | 0.4% | 0.8% | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 6.9% | 1.0% | ||
| Q4 24 | 2.3% | 0.1% | ||
| Q3 24 | 0.7% | 1.2% | ||
| Q2 24 | 0.3% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 12.67× | — | ||
| Q3 25 | 5.87× | — | ||
| Q2 25 | 0.58× | — | ||
| Q1 25 | -0.17× | — | ||
| Q4 24 | 2.04× | — | ||
| Q3 24 | 2.27× | — | ||
| Q2 24 | -0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDCC
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
